Disrupt Health Impact Fund
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Named in evidence focused on healthcare investing. While not explicitly longevity-specific in the snippet, it is clearly a health-focused capital source and OpenDrugs sits at the intersection of health, biotech, and AI research tooling.